CCL2 and neoplasm: Furthermore, in vivo MRTX treatment of 3LL ΔNRAS tumor–bearing mice led to a significant down-regulation of Ccl2 expression in the tumor (Fig. 4G), suggesting that tumor cells may be one of the main sources of this cytokine in the TME.